A molecule selected from a library of compounds that have structures similar to natural products targets several stages of the malarial parasite's life cycle, offering single-dose treatment of the disease in mouse models. See Article p.344
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Notes
References
WHO. World Malaria Report 2015 www.who.int/malaria/publications/world-malaria-report-2015/report/en (2015).
Kato, N. et al. Nature 538, 344–349 (2016).
Ashley, E. A. et al. N. Engl. J. Med. 371, 411–423 (2014).
Leang, R. et al. Antimicrob. Ag. Chemother. 59, 4719–4726 (2015).
Lowe, J. T. et al. J. Org. Chem. 77, 7187–7211 (2012).
Wells, T. N. C., Hooft van Huijsduijnen, R. & Van Voorhis, W. C. Nature Rev. Drug Discov. 14, 424–442 (2015).
Pham, J. S. et al. Int. J. Parasitol. Drugs Drug Res. 4, 1–13 (2014).
Corey, V. C. et al. Nature Commun. 7, 11901 (2016).
Baragaña, B. et al. Nature 522, 315–320 (2015).
Phillips, M. A. et al. Sci. Transl. Med. 7, 296ra111 (2015).
Author information
Authors and Affiliations
Corresponding author
Related links
Rights and permissions
About this article
Cite this article
Fidock, D. Chemical diversity targets malaria. Nature 538, 323–325 (2016). https://doi.org/10.1038/nature19481
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature19481
